Chen Hao: Changing the status quo of medical research and industry

"If our medical research system and industry are still two skins, I am afraid that the ability of pharmaceutical innovation will never go up." Minister of Health Chen Hao recently attended the 9th General Assembly of China Pharmaceutical Industry Research and Development Promotion Association (Pharmacy Promotion Association) At the third meeting, it was pointed out that while strengthening the dominant position of enterprises in technological innovation, pharmaceutical research institutes and colleges and universities must also respect and support pharmaceutical companies, and form a system of innovation for medicines and medical devices integrating “production, study, and use”. mechanism.

Chen Xi said that in recent years, China has made important progress in drug inheritance innovation, but industrial innovation capacity is not strong. Pharmaceutical scientific research institutes and colleges and universities should step out of the ivory tower, lay down their bodies, take the initiative to serve the enterprise, and change the status quo of medical research and industry. At the same time, companies must also strengthen cooperation with the clinical medical community.

In response to the current problems in the tender procurement process of medicines, Chen Wei said that we must reduce the prices of drugs that are too high, and we must also correct the behaviors of bids and bids below the cost price and interfere with the normal pharmaceutical market order. Only in this way can we ensure basic The quality and safety of the drug and the entire drug supply system. At the same time, he also demanded that pharmaceutical companies further enhance their sense of social responsibility, establish and improve the integrity system, and place quality and safety of drugs above all else.